Official announcements
messages in brief
|
12/03/2020
NTA Vol. 2C: The "Guideline on the Packaging Information of medicinal products for human use authorised by the Community" - so called "Blue-Box Guideline für zentralen Zulassungen" can be found on the following website::…
Recall
|
Medicines
|
12/03/2020
Recall due to increased reports of ring breakage
Safety warnings
|
Blood & Tissue
|
11/03/2020
Only available in German
messages in brief
|
10/03/2020
Das BASG überwacht aufmerksam gemeinsam mit der europäischen Arzneimittelagentur EMA und den nationalen Partnern der Mitgliedstaaten die möglichen Auswirkungen des Ausbruchs der neuartigen Coronavirus-Krankheit (COVID-19) auf die pharmazeutischen Lieferketten.
Safety warnings
|
Blood & Tissue
|
10/03/2020
Only available in German
Recall
|
Medicines
|
03/03/2020
Recall due to particles affecting batches 8234, 8235 und 8236
Recall
|
Medicines
|
26/02/2020
Recall due to reduced active ingredient content
messages in brief
|
13/02/2020
According to § 14 of the Federal Disability Equality Act (BGStG) Marketing authorization holders are obliged to provide their Package Leaflets in an accessible format
Safety warnings
|
Medicines
|
11/02/2020
The all-clear can be given, because samples of the active substance noscapine from manufacturer and affected pharmacies have been examined in the meantime.